15 research outputs found

    Baseline exercise tests at inclusion for LIPOXmax-RĂ©union randomized controlled trial participants.

    No full text
    <p>Data are means ± SD. FFM: Fat Free Mass. HR: Heart Rate. RER: Respiratory Exchange Ratio. W: Power. MFO: Maximal Fat Oxidation. p-values refer to comparisons between the three groups by one-way ANOVA or Kruskal-Wallis non parametric tests (*).</p><p>Baseline exercise tests at inclusion for LIPOXmax-Réunion randomized controlled trial participants.</p

    Longitudinal evolution of metabolic characteristics (month-0, month-3 and month-5) in LIPOXmax-RĂ©union randomized controlled trial participants.

    No full text
    <p>Data are means ± SD for 103 subjects were followed-up at M0, M3 and M5). For MFO (mg/min/kg FFM), data are mean ± SD for n = 109 (subjects who participated at M0 and M5), because fat free mass DXA was measured only at M0 and at M5. M3: third month of intervention. M5: fifth month of intervention.HOMA-IR index: HOmeostasis Model Assessment estimated insulin resistance index. MFO: Maximal Fat Oxidation. FFM: Fat Free Mass. Repeated-measures ANOVA p-values represent the main effects of time (t), g (group) and the interaction effect (time *group).</p><p>Longitudinal evolution of metabolic characteristics (month-0, month-3 and month-5) in LIPOXmax-Réunion randomized controlled trial participants.</p

    Post-hoc analysis (Repeated–measures ANOVA P values) for longitudinal evolution of metabolic characteristics (month-0, month-3 and month-5).

    No full text
    <p>HOMA-IR index: HOmeostasis Model Assessment estimated insulin resistance index. MFO: Maximal Fat Oxidation. FFM: Fat Free Mass. Repeated-measures ANOVA P values represent the main effects of time (t), g (group) and the interaction effect (time *group). Post-hoc analysis (G1 vs G2, G1 vs G3, G2 vs G3) was performed to compare groups two-by-two at p = 0.0167 significance level according to Bonferroni’s method.</p><p>Post-hoc analysis (Repeated–measures ANOVA P values) for longitudinal evolution of metabolic characteristics (month-0, month-3 and month-5).</p

    Baseline inclusion characteristics for LIPOXmax-RĂ©union randomized controlled trial participants.

    No full text
    <p><sup>†</sup> Data are medians and interquartile range.</p><p><sup>‡</sup> Data are medians and interquartile range. Otherwise, data are means ± SD or percentages. CMU: universal health coverage.</p><p>HOMA-IR index: Homeostasis Model Assessment estimated insulin resistance index. p-values refer to comparison between the three groups by one-way ANOVA or Kruskal-Wallis non parametric tests (*) for quantitative variables, and by Chi2 test or Fisher exact tests (*) for qualitative variables.</p><p>Baseline inclusion characteristics for LIPOXmax-Réunion randomized controlled trial participants.</p

    Synoptic view of CoPanFlu protocol implementation.

    No full text
    <p>Green and violet lines represent the number of blood samples collected from the cohort, on inclusion (weeks 30–44) and at the end of the study (weeks 45–52) respectively (Y axis at the left: number of samples collected). Shaded area represents the profile of the epidemic wave in Reunion Island according to the local epidemiology surveillance unit (Y axis at the right: estimated number of symptomatic influenza cases occurring in the island); X axis: calendar weeks.</p
    corecore